Response to "Comment on 'Piriformis muscle syndrome: Diagnostic criteria and treatment of a monocentric series of 250 patients"' by F. Michel et al

Ann Phys Rehabil Med. 2016 Sep;59(4):286-7. doi: 10.1016/j.rehab.2016.03.008. Epub 2016 May 4.

¹ Physical Medicine and Rehabilitation Department, hôpital Jean-Minjoz, CHRU, 25000 Besançon, France. Electronic address: fmichel@chu-besancon.fr.
² Physical Medicine and Rehabilitation Department, hôpital Jean-Minjoz, CHRU, 25000 Besançon, France.
³ Clinical Investigation, Biotherapy Department CBT-506 & Rheumatology, CHRU de Besançon, 25000 Besançon, France; University Department of Therapy and Reception Team 4266 Pathogenic Agents and Inflammation, IFR133, université de Franche-Comté, 25000 Besançon, France.
⁴ Department of Neuromuscular Examinations and Diseases, hôpital Jean-Minjoz, CHRU, 25000 Besançon, France; Anatomy Laboratory, université de Franche-Comté, 25000 Besançon, France.
⁵ Department of Neuromuscular Examinations and Diseases, hôpital Jean-Minjoz, CHRU, 25000 Besançon, France.
⁶ Department of Orthopedic and Traumatology Surgery, Plastic and Reconstruction Surgery, hôpital Jean-Minjoz, CHRU, 25000 Besançon, France.
⁷ Physical Medicine and Rehabilitation Department, hôpital Jean-Minjoz, CHRU, 25000 Besançon, France; Anatomy Laboratory, université de Franche-Comté, 25000 Besançon, France.

No abstract available

Keywords: Diagnosis; Onabotulinumtoxin A; Piriformis muscle syndrome; Sciatic nerve.

Publication types